DIA 2020 Global Annual Meeting

This event is now offered in a new entirely virtual format.

Back to Agenda

Best Practices for Virtual Meetings with FDA!

Session Chair(s)

Khyati Roberts, RPh

Retired

Retired, United States

Meetings with FDA during development are key to inform product strategies and increase probability of success. Given the recent COVID-19 pandemic, everyone has adjusted to a new 'norm' - virtual meetings. Hear from FDA and industry experts on best practices for holding a virtual meetings.

Learning Objective : Identify the best practices for virtual PDUFA meetings; Describe how to change the way you prepare for virtual meetings.

Speaker(s)

Best Practices for Virtual Meetings: Industry Perspective

Todd Paporello, PharmD, MBA

Sanofi, United States

Vice President, Global Head of Regulatory Affairs, Specialty Care

FDA Update and Best Practices for Virtual Meetings

Khushboo Sharma, MBA

Accumulus Synergy, United States

Chief Regulatory Innovation Officer

Best Practices for Meeting Requests and Briefing Packages

Lisa Yanoff, MD

FDA, United States

Division Director, OND, CDER

Have an account?